NextCure

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.

CEO

Michael S. Richman

CEOMichael S. Richman

Employees

Employees87

Headquarters

Beltsville, Maryland

HeadquartersBeltsville, Maryland

Founded

2015

Founded2015

Employees

Employees87

NXTC Key Statistics

Market cap

76.59M

Market cap76.59M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

64.43K

Average volume64.43K

High today

$2.86

High today$2.86

Low today

$2.75

Low today$2.75

Open price

$2.80

Open price$2.80

Volume

42.77K

Volume42.77K

52 Week high

$9.18

52 Week high$9.18

52 Week low

$2.66

52 Week low$2.66

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

25%

Sell

12.5%

NXTC Earnings

-$0.75

-$0.50

-$0.25

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, After Hours

ActualExpected Nov 3, After Hours